Clinical Trial Update: Hematopoietic Stem Cell Transplantation in Autoimmune-Related Retinopathy(ARRON) [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating hematopoietic stem cell transplantation for autoimmune-related retinopathy (ARRON) has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autoimmune Retinopathy

Drugs mentioned

• Hematopoietic stem cell transplantation

Snippet

Sponsor: Richard Burt, MD | Conditions: Retinal Disease | Phase 1 | Status: TERMINATED